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Activation-induced cytidine deaminase (AID) initiates
both somatic hypermutation (SHM) for antibody af-
finity maturation and DNA breakage for antibody
class switch recombination (CSR) via transcription-
dependent cytidine deamination of single-stranded
DNA targets. Though largely specific for immuno-
globulin genes, AID also acts on a limited set of off-
targets, generating oncogenic translocations and
mutations that contribute to B cell lymphoma. How
AID is recruited to off-targets has been a long-stand-
ing mystery. Based on deep GRO-seq studies of
mouse and human B lineage cells activated for CSR
or SHM, we report that most robust AID off-target
translocations occur within highly focal regions of
target genes in which sense and antisense transcrip-
tion converge. Moreover, we found that such AID-
targeting ‘‘convergent’’ transcription arises from
antisense transcription that emanates from super-
enhancers within sense transcribed gene bodies.
Our findings provide an explanation for AID off-tar-
geting to a small subset of mostly lineage-specific
genes in activated B cells.
INTRODUCTION
The B cell antigen receptor (BCR) is comprised of immunoglob-
ulin (Ig) heavy (IgH) and light (IgL) chains. In response to antigen
activation, B lymphocytes in peripheral lymphoid organs un-
dergo somatic hypermutation (SHM) and IgH class switch
recombination (CSR) and ultimately secrete their BCR as an anti-1538 Cell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc.body. SHM diversifies antibody repertoires by introducing high-
frequency mutations into IgH and IgL variable region exons (Di
Noia and Neuberger, 2007). SHM occurs in germinal centers
(GCs) of peripheral lymphoid tissues, where B cells are selected
for mutations that generate BCRs with increased antigen affinity
(Victora and Nussenzweig, 2012). IgH CSR involves generation
and joining of IgH locus DSBs in switch (S) regions that precede
various sets of IgH CH exons (CHs) to replace the initially ex-
pressed CH with a downstream CH, thereby producing anti-
bodies with different effector functions (Matthews et al., 2014).
Both SHM and CSR are initiated by activation-induced cytidine
deaminase (AID) (Muramatsu et al., 2000), which deaminates
cytosine to uridine on single-stranded DNA (ssDNA) (Di Noia
and Neuberger, 2007). Mismatches created by these deami-
nated cytidines are processed into mutations or DSBs during
SHM and CSR, respectively, through a process that employs ac-
tivities of normal base excision or mismatch repair pathways (Di
Noia and Neuberger, 2007).
Within target sequences, AID cytidine deamination focuses on
3–4 bp ‘‘SHM’’ motifs that are greatly enriched in S regions and in
portions of variable region exons that encode antigen-binding
sites (Di Noia and Neuberger, 2007). Transcription is required
for AID targeting during SHM and CSR (Alt et al., 2013; Storb,
2014). In this regard, SHM of V(D)J exons in GC B cells begins
150 bp downstream of the transcription start site (TSS) and ta-
pers off 1–2 kb downstream (Liu and Schatz, 2009). Likewise,
each CH has a promoter upstream of the S region that upon in-
duction by external signals generates transcription through the
S region and, thereby, targets AID (Matthews et al., 2014).Mouse
and human S regions also have a highly G-rich nontemplate
strand that upon transcription forms stable R-loops that provide
ssDNA to augment AID targeting (Matthews et al., 2014; Alt et al.,
2013). RNA polymerase II (Pol II) has been implicated in directing
AID to Ig gene SHM and CSR targets through a transcription
coupled mechanism (Storb, 2014) that involves AID association
with the Spt5 transcription cofactor in the context of Pol II stalling
(Pavri et al., 2010). R loops or other aspects of repetitive S region
structure may augment AID access by promoting Pol II stalling
(Rajagopal et al., 2009; Wang et al., 2009). Once AID is recruited
to Ig targets, replication protein A (RPA) and the RNA exosome
RNA degradation complex contribute to generating requisite
ssDNA substrates (Basu et al., 2011; Matthews et al., 2014; Pe-
fanis et al., 2014).
Beyond Ig gene targets, AID initiates recurrent mutations or
DSBs in a small subset of non-Ig genes collectively termed AID
‘‘off-target’’ genes (Pasqualucci et al., 2001; Chiarle et al.,
2011; Klein et al., 2011; Liu et al., 2008). Off-target AID activity
promotes translocations between Ig loci and cellular oncogenes,
as well as SHMs of oncogenes associated with B cell lym-
phomas (Alt et al., 2013; Ku¨ppers and Dalla-Favera, 2001). Iden-
tification of AID off-targets has been facilitated by genome-wide
translocation cloning methods (Chiarle et al., 2011; Klein et al.,
2011) and other large-scale approaches (Liu et al., 2008; Ya-
mane et al., 2011). In general, AID activity occurs at much lower
levels on off-targets than on Ig genes (Liu and Schatz, 2009; Ya-
mane et al., 2011; Chiarle et al., 2011; Klein et al., 2011), likely
due to specialized AID-targeting features of the latter. AID off-
target sequences are not enriched in AID hotspot motifs relative
to the genome in general (Duke et al., 2013). Consistent with a
role for transcription, AID off-target activity is most abundant
on transcribed genes downstream of their TSSs (Pasqualucci
et al., 2001; Liu et al., 2008; Chiarle et al., 2011; Klein et al.,
2011). However, transcription per se is not sufficient to target
AID, as most transcribed genes are not AID off-targets (Alt
et al., 2013; Liu and Schatz, 2009). Next-generation sequencing
studies revealed unexpected transcriptional features, including
divergent sense and antisense transcription at TSSs (Wu and
Sharp, 2013; Adelman and Lis, 2012) and frequent promoter
proximal Pol II pausing (Adelman and Lis, 2012). But, divergent
transcription (DivT) from TSSs occurs in over half of all genes
and generally does not map directly to sites of AID off-target ac-
tivity (Chiarle et al., 2011; see below). Likewise, transcriptional
pausing alone cannot explain AID off-targeting, because more
than 30% of transcribed genes have paused Pol II (Adelman
and Lis, 2012). Thus, mechanisms that lead to recurrent AID tar-
geting may arise from previously unrecognized transcriptional or
epigenetic determinants (Alt et al., 2013).
Global run-on sequencing (GRO-seq) detects nascent tran-
scripts generated by transcriptionally engagedRNApolymerases
(Core et al., 2008). GRO-seq revealed that a large fraction of in-
tergenic regions are transcribed, with a subset emanating from
transcriptional enhancers (Wang et al., 2011). Enhancers are
sequence-defined, cis-regulatory elements that influence target
gene expression irrespective of orientation (Levine et al., 2014).
Both enhancers within genes (intragenic) and intergenic en-
hancers may regulate target promoters locally and over long
distances (Levine et al., 2014). Active enhancer sequences are
commonly transcribed by RNA Pol II generating so-called
‘‘enhancer RNAs’’ (eRNAs), and transcription arising from en-
hancers is often divergent, with both sense and antisense tran-
scription emanating from enhancer elements (Natoli and Andrau,
2012; Wang et al., 2011). Various regulatory functions have beenCascribed to eRNAs and other noncoding RNAs (Lam et al., 2014),
however,muchof noncodingRNAbiology is not fully understood.
Enhancers are comprised of discrete or clustered transcription
factor binding sequences. A common feature of active en-
hancers is chromatin that is characteristically modified by acet-
ylation (e.g., histone 3 lysine 27; H3K27Ac) andmethylation (e.g.,
histone 3 lysine 4 mono-methylation; H3K4me1) (Creyghton
et al., 2010). An unexpected asymmetry in the regional allocation
of enhancer factors and enrichment for enhancer marks within
and unique to each mammalian cell type studied revealed a sub-
set of so-called super-enhancers (SEs) that feature clusters of
hyperacetylated and actively transcribed enhancers that, on
average, are 10-fold longer than other ‘‘typical’’ enhancers
(Whyte et al., 2013; Love´n et al., 2013). Like locus control
regions, SEs regulate genes involved in specialized cellular func-
tion (Parker et al., 2013) and are found within or adjacent to line-
age-specifying transcription factor genes (Whyte et al., 2013;
Hnisz et al., 2013). In cancer, SEs frequently enforce oncogene
expression (Love´n et al., 2013) and, thereby, contribute to tumor
pathogenesis. For example, translocations that juxtapose c-myc
to the IgH 30 regulatory region, a known SE (Delmore et al., 2011;
Chapuy et al., 2013), promote B cell lymphoma by activating
c-myc over long distances (Gostissa et al., 2009). In this context,
selectively blocking SE activity with bromodomain and extra-ter-
minal domain (BET) inhibitors is a promising cancer therapeutic
strategy (Delmore et al., 2011; Love´n et al., 2013; Chapuy
et al., 2013).
Here, we report that the majority of detectable AID off-target
activity in a variety of mouse and human lymphoid or nonlym-
phoid cell types occurs within focal regions of overlapping
sense/antisense transcription within intragenic SEs.
RESULTS
Deep GRO-Seq Transcription Profiles of Naive, GC,
and CSR-Activated B Cells
To elucidate transcriptional features that influence AID targeting
genome-wide, we applied GRO-seq to splenic naive, GC, and
CSR-activated B cells at much greater depth than done previ-
ously. Naive splenic B cells were purified (Figure S1A available
online) and then cultured in the presence of aCD40 plus inter-
leukin-4 (IL4) for 60 hr to stimulate AID induction and CSR to
IgG1 and IgE (Figure S1A). Splenic GC B cells were purified
from sheep red blood cell immunized mice (Figure S1A) and
confirmed to be >90% pure (Figures S1B–S1D). Three indepen-
dent GRO-seq biological replicates were performed for each cell
type and gave highly reproducible results (Figure S1E). Tran-
scription profiles of over 20,000 genes revealed distinct (but
overlapping) gene expression patterns for each cell type that
were further classified by gene ontology terms (Figure S1G; Ta-
ble S1). As expected (Core et al., 2008; Chiarle et al., 2011),
GRO-seq revealed divergent sense and antisense transcription
at TSSs of over 50% of the genes in each of the three cell types
(Figures 1 and S1F). In-depth examination of sense transcription
profiles of several ‘‘signature’’ genes illustrates the specificity of
purified cell populations. For example, Aicda sense transcription
reflects AID protein expression in the three cell types, with high
levels in GC B cells and activated B cells; but none detectableell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc. 1539
Figure 1. GRO-Seq Profiles of Naive,
Germinal Center, and CSR-Activated B Cells
GRO-seq profiles of four representative genes are
shown for different B cell types. The y axis in-
dicates GRO-seq counts normalized to number of
reads per million. Gene sense and antisense
transcription are displayed in blue and red,
respectively. Gene exons are illustrated by
squares along gene bodies at the top of each
panel. Arrows indicate TSSs and direction of
sense transcription. Genome coordinates (mm9/
NCBI37) are labeled at the bottom. All the profiles
were generated from merged data of three inde-
pendent experiments, which individually showed
similar patterns.
See also Figure S1 and Table S1.in naive B cells (Figure 1). In contrast, several GC B cell-specific
genes, including SLIP-GC (Richter et al., 2009) and Bcl6 (Basso
and Dalla-Favera, 2010), had high sense transcription through
their gene bodies in GCB cells, but not in naive or CSR-activated
B cells (Figure 1). Finally, Bcl2, which is expressed in CSR-acti-
vated but not in GCB cells (Liu et al., 1991), showed correspond-
ing sense transcription patterns (Figure 1).
While IgHCH exonswere appropriately transcribed in the three
cell populations (Figure S1H), transcription within core S regions
could not be mapped due to their abundant repetitive sequence
(Pavri et al., 2010). All analyzed mice had a clonal knock-in VH(D)
JH exon (VHB1-8) (Sonoda et al., 1997), which showed active
transcription at its upstream regions in all three cell types (Fig-
ure S1H). However, detailed analyses of transcription through
the body of the VHB1-8 allele was not possible (Figure S1H);
because it uses a member of the VHJ558 family, which contains
many highly related, unexpressed upstream copies (Brodeur and
Riblet, 1984).
Enhanced Identification of AID Off-Target Sites in
aCD40 plus IL4-Stimulated B Cells
We developed high-throughput genome-wide translocation
sequencing (HTGTS) tomap, at the nucleotide level, translocation
junctions between bait I-SceI nuclease generated DSBs in c-myc
and other endogenous DSBs (Chiarle et al., 2011). Identification
of DSB hotspots from a fixed chromosomal site is facilitated by
ability of recurrent DSBs to dominate genome-wide translocation
landscapes due to cellular heterogeneity in 3D genome organiza-
tion (Zhang et al., 2012). Beyond expected Ig locus targets, our
prior HTGTS studies revealed 15 non-Ig genes that are recurrent
targets of AID-initiated DSBs and translocations (Chiarle et al.,
2011) (Table S2). To increase the depth of HTGTS AID off-target
data and allow better comparison with deeper GRO-seq tran-
scription profiles, we further employed amodified, more sensitive
HTGTS approach (Frock et al., 2015), coupled with ataxia telan-
giectasia mutated (ATM)-deficient CSR-activated B cells (Hu
et al., 2014). This combined approach identified highly clustered
AID-dependent off-target DSB sites within 36 additional genes
(Figure S2A; Extended Experimental Procedures; Table S2).
Overall, we now have identified 51 highly focal AID off-target1540 Cell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc.DSB/translocation sites in aCD40 plus IL4-stimulated B cells (Ta-
ble S2). Nearly 90% of the new off-target set was validated in WT
B cells by HTGTS and/or by an independent method (Qian et al.,
2014 in this issue ofCell) (ExtendedExperimental Procedures). As
previously found for our more limited set of AID off-target sites
(Chiarle et al., 2011), many of our new AID off-targets occurred
within genes that have divergently transcribed TSSs; but the focal
sites of HTGTS junctions within them were downstream of and
distinct from divergently transcribed TSSs (Chiarle et al., 2011)
(Figure 2). Thus, we were compelled to search for other factors
that promote such focal AID off-targeting. As we found no enrich-
ment for known AID targeting motifs in these regions (Extended
Experimental Procedures), we focused our search on potentially
novel transcriptional and/or epigenetic features and, as
described below, identified both.
AID Off-Targets Cluster at Sense/Antisense
Transcription Sites Downstream of the TSS
With our present, substantially deeper, GRO-seq data sets, we
further analyzed potential relationships between sense/anti-
sense transcription and AID off-target sites in aCD40 plus IL4-
activated B cells. Initially, we visually inspected three linked
AID off-target sites, including sites in the previously character-
ized IL4r and IL21r genes (Chiarle et al., 2011) and a newly iden-
tified site in Nsmce1. In each of these linked genes, HTGTS
translocation junctions were tightly clustered in a region down-
stream of the TSS (Figure 2A). Moreover, in each, translocation
clusters fell within sites that exhibited enriched, overlapping
sense and antisense transcription to which we heretofore apply
the term ‘‘convergent transcription’’ (ConvT) (Figures 2A and 3A).
We also found a robust AID off-target site within the AID gene
(Aicda) itself (Figure 2B; Table S2). Aicda is associated with
five enhancers that lie upstream, within, or downstream of the
gene body (Kieffer-Kwon et al., 2013; Matthews et al., 2014)
(Figure 2B). Four of these enhancers showed both sense and
antisense transcription, likely at least in part in the context of
generating eRNAs (Natoli and Andrau, 2012) (Figure 2B).
Notably, the major focal cluster of AID off-target sites in and
around Aicda fell within a ConvT region associated with
enhancer 4 downstream of the TSS (Figure 2B).
AB
Figure 2. AID Off-Target Translocations
Cluster within Regions of ConvT and SEs
(A) HTGTS, GRO-seq, ConvT, and H3K27Ac pro-
files in the vicinity of Nsmce1, IL4ra, and IL21r
genes. Top: HTGTS junctions are indicated by
black bars. Middle (GRO-seq): GRO-seq-deter-
mined sense and antisense transcription is dis-
played in blue and red, respectively. ConvT regions
are shown as green bars at the bottom with the
darkest shades corresponding to highest levels of
ConvT as calculated by the geometric means of
sense and antisense transcription reads (see
Extended Experimental Procedures). A scale bar is
shown below the ConvT label. Bottom (H3K27Ac
and SE): the H3K27Ac ChIP-seq profile is shown in
orange and identified SEs depicted below with
orange bars. Nsmce1 TSS is manually curated
based on GRO-seq profile.
(B) Profile of AICDA gene. Known AICDA en-
hancers are represented as E1–E5 with solid
circles. To represent lower level transcription of
certain enhancers, a smaller scale is used for E1–
E3. Genome coordinates (mm9/NCBI37) are at the
bottom of each panel. Other details are the same
as for (A).
See also Figure S2 and Table S2.Genome-wide Association of ConvT andAIDOff-Targets
in CSR-Activated B Cells
Visual inspection of AID off-target sites in additional genes re-
vealed similar coincidence of regions of robust sense/antisense
(S/AS) ConvT downstream of the TSS with focal clusters of
AID-dependent off-target translocations (see below, Figure S2),
leading us to examine this potentially striking association
genome-wide. While metagene profiles of GRO-seq data from
aCD40 plus IL4-activated B cells confirmed expected DivT at
many TSSs (Wu and Sharp, 2013), they did not reveal similarly
abundant convergent transcription (Figure S1F). Thus, at least
at robust levels, convergent transcription likely occurs in a
much smaller fraction of genes (Figure S1F). For further analyses,
we developed a computational pipeline to specifically identify
S/AS ConvT regions genome-wide using deep GRO-seq data
sets (Figure 3A; Extended Experimental Procedures). Strikingly,
among the 51 AID off-target genes, 48 (94%) had their highly
clustered AID off-target translocations within regions associated
with S/AS convergent transcription (Figure 3B). We randomly
sampled convergent transcription of regions, in the top three
transcription-level deciles, that were similar in size to those of
AID off-target regions and found a much lower association with
convergent transcription than for AID off-target regions (Fig-
ure S3A). This finding shows that AID off-targets are highly en-
riched at ConvT sites. Finally, concurrency between S/AS
convergent transcription and AID off-target translocations was
much higher in aCD40 plus IL4-activated B cells (94%) than in
naive (49%) or GC (63%) B cells, consistent the notion that not
all AID off-targets would be shared among three cell types with
overlapping, but clearly distinct, transcription profiles (Figures
3B and S3B; also see below).
To further examine the relationship between ConvT and AID
targeting, we calculated the geometric mean of GRO-seq senseCand antisense transcription reads in regions of interest to quantify
degree of convergent transcription (Extended Experimental
Procedures) and divided the values into deciles displayed by
different shades of green bars below the GRO-seq profiles (Fig-
ures 2 andS2; dark green is highest and light green lowest levels).
For most AID off-targets, HTGTS junctions clustered in regions
with the most abundant ConvT (Figures 2 and S2). Furthermore,
ConvT associated with AID off-targets was substantially greater
than that at other genomic loci (Figure S3C). In addition, within
AID off-target ConvT regions, the highest density of transloca-
tions occurred at sites with the most robust ConvT (Figure 3C).
We further evaluated this relationship by determining how varia-
tions in sequencing depth influenced identification of ConvT.
Even with our current very deep sequencing depth (>306 million
mappable reads),we did not reach saturation of the total length of
ConvT regions (Figure S3D), consistent with (at least low-level)
pervasive transcription of the genome (Jacquier, 2009). In
contrast, we reached saturation of the concurrency of AID off-tar-
gets with ConvT regions at 40% of our current GRO-seq depth
(120 million mappable reads; Figure S3D), confirming that most
AID off-target DSB/translocation regions detectable by HTGTS
in aCD40 plus IL4-stimulated B cells are associated with rela-
tively strong convergent transcription (Figures 3C and S3D).
Convergent Transcription at AID Off-Targets Arises
from Intragenic SEs
ConvT of overlapping genes was first described in bacterio-
phage lambda (Ward and Murray, 1979) and has been associ-
ated with transcriptional gene silencing (Gullerova and Proud-
foot, 2012) and RNA Pol II collision (Hobson et al., 2012).
Considering that intragenic antisense transcription associated
with AID-off target sequences may arise from enhancer ele-
ments, we explored whether intragenic SEs were enriched forell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc. 1541
A B C Figure 3. AID Off-Targets Correlate with
ConvT in CSR-Activated B Cells
(A) Pipeline for identification of ConvT regions. Raw
GRO-seq reads were aligned to the genome and
transcripts were identified de novo. A ‘‘ConvT’’ re-
gion was defined as sense and antisense tran-
scription overlaps that were longer than 100 bp.
See Extended Experimental Procedures for details.
(B) The percentage of the 51 AID off-target regions
identified in CSR-activated B cells that were
associated with ConvT regions in the three listed
cell populations is the indicated by the green bars.
(C) Numbers of translocation junctions per kb (y
axis) plotted against ConvT levels (x axis) of all
individual AID off-target regions except Pvt1 (see
Extended Experimental Procedures). Pearson’s
correlation coefficient and two-tailed p value are
indicated.
See also Figure S3.AID off-targets compared to typical enhancers. Enhancer re-
gions were identified by triplicate chromatin immunoprecipita-
tion sequencing (ChIP-seq) using an antibody to the active
enhancer histone mark H3K27Ac in chromatin purified from
aCD40 plus IL4-stimulated B cells (Figure S4A). SEs were called
for regions of asymmetric, high enrichment for H3K27Ac, as pre-
viously described (Whyte et al., 2013). We found the Aicda locus
to be largely encompassed within a SE in CSR-activated B cells
with robust H3K27Ac signals over E1, E2, E3, and E4 (Figure 2B),
the active enhancers in CSR-activated B cells (Kieffer-Kwon
et al., 2013;Matthews et al., 2014). Notably, E4 also corresponds
in position to a cluster of HTGTS junctions and robust ConvT
(Figure 2B). Likewise, the Nsmce1, IL4ra, Il21r, and many other
AID off-target genes were each associated with SEs and again
the peak of HTGTS junctions and regions of robust ConvT
occurred within regions of robust H3K27Ac SE signals (Figures
2A and S2).
We performed an unbiased association analysis between the
51 AID off-targets identified by HTGTS and the non-Ig 448 SEs
that we identified in aCD40 plus IL4-activated B cells. These
studies revealed that 50 of the 51 AID off-target genes in these
cells are associated with SEs and that the discrete translocation
clusters were within SEs (Figure 4A). Notably, the single AID off-
target region not within a SE (under the current cutoff for SE iden-
tification; Extended Experimental Procedures) was in a typical
enhancer (Table S2). In addition, 47 (92%) of the AID off-target
translocation clusters were within regions of SEs that overlap
with annotated gene bodies (Figure 4A). The other three HTGTS
off-target translocation clusters occurred within transcribed re-
gions of SEs that have not yet been assigned to a target gene
(Table S3). As a comparison, random samplings of transcribed
genomic regions corresponding in size to those of AID off-tar-
gets yielded at most three (6%) that overlapped with SEs. Inde-
pendent analysis of the relationship between HTGTS hotspots
and H3K27Ac ChIP-seq using an orthogonal computational
method identified 41 AID off-targets within SE domains (Figures
S4C and S4D), including additional off-targets that correlated
with robust ConvT (Figure S2; Table S2; Extended Experimental
Procedures). Finally, within a given AID off-target region, translo-
cation junction frequency highly correlated with H3K27Ac abun-1542 Cell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc.dance (Figure S4B). In this regard, SEs associated with AID
off-target sequences were more enriched for H3K27Ac, com-
pared to other SEs (Figure 4B). Thus, the relative activity of
SEs, estimated by regional histone acetylation, correlates with
the frequency of AID off-targets within them.
Themajority (30 of 51) of the AID off-target genes had a SE that
overlapped with the region just downstream of the TSS that was
enriched in AID off-targets, as represented by the CD83 gene
(Figures 4C and S2). In addition, a number (12 of 51) of the AID
targets were relatively small genes, such as Pim1, that were
locatedwithin large SEs and, correspondingly, off-target translo-
cations tended to span the gene body (Figures 4D and S2).
Several AID off-target genes (3 of 51) were large genes, such
as Pvt1, the well-known translocation target downstream of c-
myc, in which translocations clustered within SEs that occurred
inside the gene body (Figure 4E). Finally, the remainder (6 of 51)
fell into a heterogeneous set in which AID off-target transloca-
tions clustered into convergently transcribed SE domains that,
for various reasons were not yet assignable to a specific gene
(e.g., Gpr183; Figure S2C).
Intragenic SEs with Robust ConvT Represent the Most
Common AID Off-Targets
Nearly all AID off-target clusters identified by HTGTS in aCD40
plus IL4-activated B cells are associated with SEs; yet, only a
subset of SEs are AID off-targets. Motivated by the putative
contribution of S/AS eRNA transcription to translocation fre-
quency, we compared regions of AID off-target genes where
SEs overlapwith the gene body (intragenic SEs) to regions where
SEs lie outside the gene body (intergenic SEs) and to regions of
gene bodies that do not overlap with SEs (nonoverlapping gene
region), for translocation density (translocations per 1 kb; Fig-
ure 5A) and for ConvT levels (geometric means; Figure 5A). We
observed that translocation junction density and ConvT levels
in AID off-target regions are highly enriched among intragenic
SEs compared to both intergenic SEs and nonoverlapping
gene regions (Figure 5A; upper). Despite this enrichment, only
10% of all intragenic SEs in the CSR-activated B cells are
AID off-targets (Figure 4A; Table S3) and other SE-gene overlap




B Figure 4. AIDOff-Target ConvT Arising from
Intragenic SEs
(A) Venn diagram showing the number of AID off-
target regions that overlapped with total non-Ig
SEs (448) and with non-Ig SEs overlapping with
Gene Bodies (376).
(B) H3K27Ac signals of AID off-target-associated
SEs (orange)andtheotherSEs (cyan)areplotted.AID
off-target-associated SEs had a stronger H3K27Ac
signal (Mann-Whitney U test, p value = 0.004).
For C, D, and E, representative AID off-targets are
shown based on the SE location indicated in the di-
agram at the top of each panel.
(C) Many AID targets locate downstream of TSSs
where SEs and genes overlap. CD83 is shown as an
example.
(D) For some relatively small genes located within a
larger SE, nearly the whole gene body is an AID off-
target, as shown for Pim1.
(E) SEs inside of very long genes, like Pvt1 also pro-
vide focal AID off-targets. HTGTS, GRO-seq, and
H3K27Ac/SE data is illustrated for each panel as
described in Figure 2A. The relatively high HTGTS
background in Pvt1 results from long resections
downstreamof theHTGTSbaitDSB inc-myc (Chiarle
et al., 2011).
See also Figure S4 and Table S3.(Figure 5B; upper). Comparison of ConvT levels in each of the
three regions outlined above (Figures 5A and 5B, lower panels)
revealed that intragenic SEs featuring high levels of ConvT
were more frequently AID off-target regions than intragenic
SEs lacking high-level S/AS transcription (Figures 5A and 5B,
lower panels).
Finally, to further address why some SEs are AID targets and
others are not, we grouped all intragenic SEs into deciles based
on low to high convergent transcription (Figure 5C). We then
calculated the percentage of the combined 228 unique AID off-
targets revealed by HTGTS (this study) and by an independent
RPA-ChIP study (Qian et al., 2014) in CSR-activated B cells in
each decile. Strikingly, 60% of all SEs within the top two deciles
(highest convergent transcription) were sites of clustered AID off-
target DSBs and/or translocations. Comparative analysis of SEs
in these top two deciles that were AID off-targets versus those
that were not did not reveal any obvious sequence differences
(e.g., GC content or WRCH and AGCT motifs density). However,
ConvT regions associated with SEs in the top two deciles that
were AID off-targets were significantly longer than those that
were not (Figure 5D). These studies provide strong evidence
that ConvT from intergeneic SEs generates amajor class of focal
AID off-target regions.Cell 159, 1538–1548, DeAID Off-Targets in GC B Cells
Associate with Convergent
Transcription
Prior studies of a selected set of AID off-
targets divided them into three groups in
GC B cells based on mutation frequency
in Ung/Msh2 double-deficient B cells
versus AID-deficient B cells, including 15
group A genes that had high levels of mu-tation, 21 group B genes that had substantially lower levels, and
47 group C genes that were infrequently mutated (Liu et al.,
2008). Our GRO-seq analyses of GC B cells revealed that
70% of the highly mutated group A gene off-target regions,
including Pim1, Ebf1, CD83, and Ocab, overlapped with ConvT
regions (Figures 6A and 6C) that were well above simulated
background levels expected for the most highly transcribed
genes (Figure S5A). In contrast, regions reported to have low
level mutation frequency (groups B and C genes) showed low
correlations with convergent transcription (33% and 32%,
respectively; Figure 6A) that were not above simulated back-
ground concurrency (Figure S5A). Finally, of the five group A
genes that did not associate directly with convergent transcrip-
tion, SHMs in four occurred quite proximal to ConvT regions (Fig-
ure S5C). We identified SEs in GC B cells via H3K27Ac ChIP-seq
analyses.We found that someSEswere shared betweenGCand
CSR-activated B cells, while many others were found only in one
or the other cell type (Figure S5B; Table S3), consistent with the
overlapping but distinct GRO-seq profiles of these two cell types
(Figure S3B; Table S1). Of the highly mutated group A gene re-
gions, nearly half were associated with SEs (Figure 6B) and all
were associated with H3K27Ac peaks (Figures 6C and S5C).
For group B and C gene regions, concurrencies with SE werecember 18, 2014 ª2014 Elsevier Inc. 1543
AC D
B Figure 5. Convergently Transcribed Intra-
genic SEs Are Preferred AID Off-Targets
(A) Upper and lower: each SE associated with an
AID off-target region and its overlapping gene
body were divided into intergenic SEs, intragenic
SEs, and nonoverlapping gene regions as
described in the text and outlined at the top of the
panels. For all AID off-targets, the number of
translocation junctions per kb in each of the three
regions (upper panel) and convergent transcription
levels of each region (lower panel) are plotted.
(B) Upper and lower: each SE that was not asso-
ciated with an AID off-target region and its over-
lapping gene body were divided into regions as
described for (A) and translocation junction
numbers per kb (upper panel) and convergent
transcription levels (lower panel) plotted for each
region. A Mann-Whitney U test was performed to
compare two classifications of SEs for convergent
transcription ratios within each of the three re-
gions; the only significant difference found was
that the AID-off-target intragenic SEs has a
significantly higher convergent transcription ratio
than non-AID off-target intragenic SEs (p value =
1.1 3 107).
(C) All intragenic SEs were grouped into deciles
based on the ConvT levels. The fraction of AID off-
targets in each decile is indicated by gray bar.
(D) Intragenic SEs in the top two deciles are divided
into those associated with AID off-targets (60%)
and those that are not (40%). Length of ConvT
regions was plotted and found to be significantly
longer in the AID off-target-associated intragenic
SEs (Mann-Whitney U test, p value = 0.01).20% and 2%, respectively. Thus, under physiological conditions
in the GC, AID often targets convergently transcribed intragenic
SEs or, occasionally, typical enhancers.
Convergently Transcribed Intragenic SEs Target AID in
Non-B Lymphoid and Human Cells
Ectopic manipulation of endogenous SEs and ConvT regions to
assess affects on AID targeting would be problematic because
these regions are the actual AID targets. As an alternative
approach, we performed GRO-seq on mouse embryonic fibro-
blasts (MEFs) in which ectopic AID expression revealed a set
of 29 AID off-target sequences, most of which were novel
(Qian et al., 2014) (Table S4). Remarkably, we found that the
great majority of these clustered MEF translocations occurred
in ConvT regions (Figures 7A and S6A) that also were mostly
also associated with SEs (Qian et al., 2014) (Table S4). We also
tested the generality of our ConvT findings with respect to AID1544 Cell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc.off-target events observed during SHM
in the human Ramos Burkitt’s lymphoma
cell line. Strikingly, the majority of 54 AID
off-targets identified in this line again
were associated with SEs (Qian et al.,
2014), and we found that most were clus-
tered in regions of strong ConvT (Figures
7B and S6B; Table S4). As discussedbelow, we have also extended our findings to human B cell lym-
phoma translocations.
DISCUSSION
Off-Target AID Activity in Convergently Transcribed
Intragenic SEs
We report that most AID off-target DSBs and translocations in
CSR-activated B cells occur in and around ConvT regions within
genes (Figure 3). Furthermore, most of these AID off-target sites
in CSR-activated B cells occurred within portions of genes that
overlapped with enhancers, the vast majority of which were
SEs (Figure 4). Together, these findings implicate a role for SEs
within genes in generating robust ConvT and, thereby, in
creating susceptibility to AID off-target activity. Notably, we
also found that the majority of the regions with highest levels of
off-target AID activity in GC B cells or in human Ramos cells
AB
C Figure 6. ConvT and SEs Correlate with AID
Off-Targets in GC B Cells
Regions of genes containing SHMs in Ung/Msh2
double deficient GC B cells were analyzed for
convergent transcription as determined by GRO-
seq and outlined in Figure 3. GC AID off-target
group A, B, and C genes include gene regions with
high, intermediate, and low frequencies of AID-
dependent mutations, respectively (Liu et al.,
2008).
(A) Concurrency of group A, B, and C gene ConvT
regions in GC B cells.
(B) Venn diagram showing the number of group A
gene regions that overlapped with SEs and ConvT.
(C) Examples of group A gene regions are shown.
Approximately 2–3 kb regions around the TSSs of
the indicated genes are shown. The ‘‘SHM’’ dia-
gram at the top of each subpanel indicates regions
of these genes included in the prior SHM analyses
(Liu et al., 2008) with a black bar. GRO-seq profile,
ConvT, H3K27Ac ChIP-seq profile, and SEs are
shown as in Figure 2A.
See also Figure S5 and Table S3.undergoing SHM are in focal areas of target genes that contain
SEs and undergo robust ConvT (Figures 6 and 7). Even in non-
lymphoid cells (MEFs) in which AID was ectopically expressed,
we found that the great majority of 29 AID-dependent transloca-
tion clusters occurred in regions that underwent robust ConvT
(Figure 7), confirming our findings for a totally different set of
genes in a different cell type. Together, these finding strongly
support a mechanistic link between AID off-target sequences
and S/AS convergent transcription. A role for SEs in AID off-tar-
geting also has been revealed by a separate study (Qian et al.,
2014).
Potential Mechanisms by which SEs and ConvT
Contribute to AID Off-Target Activity
RNA polymerase II (Pol II) transcriptional pausing or stalling con-
tributes to directing AID to Ig gene SHM and CSR targets via a
process thought to involve AID association with the Spt5 tran-
scription cofactor (Pavri et al., 2010; Storb, 2014). Ig gene V(D)
J exons and S regions likely evolved specific features to promote
AID targeting (Alt et al., 2013). As AID off-target genes lack
consistent sequence features of Ig gene AID targets (Duke
et al., 2013), the question of how they attract AID has been
long-standing. Our current findings implicate a mechanism that
answers this question for the majority of AID off-targets (Fig-
ure 7C). Thus, most robust AID off-target DSBs, SHMs, and
translocations occur within intragenic SEs, where we find ConvT
that includes sense gene transcription and antisense transcrip-
tion emanating from the SEs. In such AID off-target regions, anti-
sense eRNA transcription generally occurs at lower levels than
sense transcription (Figures 2 and 4). Thus, most genic sense
transcription likely proceeds unimpaired to generate full length
mRNAs with only a small fraction encountering antisense tran-
scription, consistent with ability of cells to generate products
of these genes (Storb, 2014). Prior yeast studies showed that,Cwithin convergently transcribed sequences, Pol II elongation
complexes proceeding in opposite directions cannot bypass
each other, and consequential Pol II collisions lead to stalling
or stopping (Hobson et al., 2012). We propose that such Pol II
stalling due to convergent transcription leads to AID recruitment
and further downstream events similar to those implicated in
specialized Ig gene targets (Figure 7C) (Pavri et al., 2010; Basu
et al., 2011). Beyond AID recruitment, convergent transcription
could also generate ssDNA substrates for AID. Thus, following
Pol II collisions, RNA exosome or other RNase activities could
remove nascent transcripts (Basu et al., 2011; Pefanis et al.,
2014; Andersson et al., 2014) to provide local ssDNA targets
(Figure 7C).
Implications of AIDOff-Target Activity for AIDOn-Target
Ig Gene Activity
AID activity generally occurs at much higher levels on special-
ized Ig gene targets than on off-targets (Liu and Schatz, 2009;
Yamane et al., 2011; Chiarle et al., 2011; Klein et al., 2011).
Whether or not the ConvT mechanism we propose for off-tar-
gets can be applied to on-targets remains to be determined.
In CSR-activated B cells, we observed ConvT within the very
50 Sm region (Figure S1H). However, the transcription profile
of core S regions cannot be obtained due to poor mappability
of repetitive S regions (Pavri et al., 2010). Clearly, S regions
evolved specialized structural features that facilitate AID
recruitment and access to the ssDNA substrates (Alt et al.,
2013). However, mechanisms by which AID specifically targets
Ig variable region exons for SHM in GCs may be more relevant.
In this regard, a long-standing paradox involves that fact that
SHM of variable region exons occurs only in GC B cells and
not in CSR-activated B cells, even though the variable region
exons are transcribed in both (Liu and Schatz, 2009). Our
preliminary analyses reveal potentially higher relative levels ofell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc. 1545
AC
B Figure 7. Model of AID Targeting at Off-
Targets
(A) Venn diagram showing the number of AID off-
target regions that overlapped with SEs and ConvT
in MEFs with ectopic AID overexpression.
(B) Venn diagram showing number of AID off-target
regions that overlapped with SEs and ConvT in
Ramos Human Burkitt’s lymphoma cell line.
(C) Model of AID ‘‘off-targeting.’’ Left: at AID off-
targets, SEs overlap with gene bodies and this
combination generates regions of sense/antisense
convergent transcription due to sense gene tran-
scription encountering the enhancer antisense
transcription. Right: stalled RNA polymerase with
the help of Spt5 recruits AID and generates regions
of ssDNA. RNA Exosome or other RNases degrade
the aborted sense and antisense transcripts and
works together with RPA to help AID access to the
ssDNA substrates. Some aspects adapted from
Basu et al. (2011). See Discussion for other details.
See also Figure S6 and Table S4.antisense to sense transcription on the downstream edge of the
KI V(D)J (VB1-8) exon in GC versus naive or CSR-activated B
cells (Figure S1H). However, as we cannot map transcription
within the main body of the KI VB1-8 due to many highly related
unexpressed, upstream VHJ558 sequences, final testing of this
potential mechanism for specific AID targeting of V(D)J exons
will require additional mouse models that eliminate sequence
redundancies.
Role of SE Transcription in Genome Instability and
Cancer
SEs are important for establishment of cell lineage and expres-
sion of cell lineage-specific genes (Whyte et al., 2013; Hnisz
et al., 2013). Correspondingly, SEs are associated frequently
with genes highly expressed in activated B cells (Table S3).
Many of the 51 genes that we have shown to have SEs that
are AID off-targets are B cell-specific genes and a notably
high proportion (25%) are known oncogenes (Figure S2B). In
this regard, many human B cell lymphomas contain transloca-
tions or mutations of oncogenes that are initiated by off-target
AID activity (Alt et al., 2013; Ku¨ppers and Dalla Favera, 2001.
Reminiscent of the AID off-targeting pattern in mouse CSR-
activated and GC B cells, human B cell oncogene translocation
sites often occur downstream of TSSs (Migliazza et al., 1995;
Pasqualucci et al., 2001; Shen et al., 1998). Indeed, we have
analyzed SEs in human tonsil B cells (enriched in GC B cells)
and found that many oncogene translocations in human B cell
lymphoma, including those in c-myc, Pax5, Bcl6, Bcl2, Pim1,
Ocab, Lcp, and Bcl7a, occur in regions downstream of TSSs
where SEs overlap with gene bodies (Figure S6C). Thus,
beyond contributing to deregulated oncogene expression (Cha-
puy et al., 2013), our findings suggest that SEs may target on-
cogenes for translocations in B cell lymphoma. Finally, AID also1546 Cell 159, 1538–1548, December 18, 2014 ª2014 Elsevier Inc.has been implicated in genomic insta-
bility and translocations in cells beyond
those of the immune system (Lin et al.,




Splenic naive B cells were purified from VHB1-8 heavy chain knock-in mice as
described (Cato et al., 2011). Naive B cells were activated with aCD40 plus IL4
for 60 hr to generate CSR-activated B cells. VHB1-8 knock-in mice were immu-
nizedwith 53 108 sheep red blood cells (SRBCs) for 9 days. Splenic GCB cells
were purified as described (Cato et al., 2011) (see Extended Experimental Pro-
cedures for details.) All animal experiments were performed under protocols
approved by the Institutional Animal Care and Use Committee of Boston Chil-
dren’s Hospital.
GRO-Seq and ChIP-Seq
GRO-seq (Core et al., 2008) and H3K27AcChIP-seq (Chapuy et al., 2013) were
performed as described. Three biological replicates of each mouse B cell type
were performed. Two biological replicates of mouse MEF experiments and
one biological replicate of Ramos experiments were performed.
AID Off-Targets
HTGTSwas performedwith aCD40 plus IL4 or RP105-activated ATM-deficient
CSR-activated B cells as described (Hu et al., 2014) and also with a new
HTGTS method (Frock et al., 2015). AID off-target coordinates were retrieved
via a new HTGTS pipeline (Frock et al., 2015) (see Extended Experimental Pro-
cedures for details).
Data Analysis
GRO-seq and ChIP-seq data sets were aligned using Bowtie software
(Langmead and Salzberg, 2012) to mouse genome build mm9/NCBI37 or
human genome build hg19/NCBI37. Uniquely mapped, nonredundant
sequence reads were retained. We used Homer software (Heinz et al.,
2010) to de novo identify transcripts from both strands of the genome in
the context of the GRO-seq data and considered broad sense/antisense
overlap regions (>100 bp) as ConvT regions. We used the MACS1.4 soft-
ware (Zhang et al., 2008) to identify regions of ChIP-seq enrichment over
background with a p value threshold of 105. We used ROSE software to
identify SEs (Whyte et al., 2013) (see Extended Experimental Procedures
for details).
ACCESSION NUMBERS
The Gene Expression Omnibus databank accession number for all deep
sequencing data reported in this paper is GSE62296.
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Supplemental Information includes Extended Experimental Procedures, six
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